| Generic Drug/Consistency Evaluation Platform |
蟹爪兰
菊芋
榆树
郁金香
吊灯扶桑
Services and Solutions
Fukangren is committed to the research and development of new drugs and the consistency evaluation of generic drugs. It has a strong team of highly educated core personnel with rich experience in new drug R&D and industrialization.
CDMO
Focus on the development of high-end preparations and international cooperation in...
About Us
Beijing Fukangren Biopharmaceutical Technology Co., Ltd. started its drug R&D service in 1999 and is the CRO company with the longest continuous service time in China. Owns 3 pharmaceutical R&D centers, 1 clinical R&D center, 4 API production bases and 1 preparation production base
Contact Us
Sound organization, high-quality quality management team, complete document management system...
Global Cooperation
Committed to research and development of new drugs and consistency evaluation of generic drugs
Innovative medicine international cooperation platform
To the future with you
Organizational Guarantee
Set up branches overseas to obtain extensive resources and information
U.S. branch
Located in San Diego Medical Valley, USA. Founded in 2014, focus on building
Innovative drug research and development platform, especially the research and development of biological products.
UK branch
Located in London, UK
Committed to investing in biomedicine, its investment series of products have entered clinical research in Europe and the United States
Cooperative research and development of innovative drugs
All over Europe, North and South America, Asia, Oceania and other regional countries
International technology output
Export domestic new technologies and new products to the world
The first successful realization of the technical export of domestic high-end preparations to the EU
Fukangren transfers paroxetine double-layer controlled release tablet technology to a famous Portuguese company bluepharma
